Delix Therapeutics
Ejecutivos
Ver el organigrama con sus 13 ejecutivos principales
Biografías más buscadas en Delix Therapeutics
Crear su alerta
para seguir los movimientos de los ejecutivos en Delix Therapeutics.
Biotecnología
Delix Therapeutics tiene 2.285 competidores entre los que se incluyen Lonza (Suiza), Eurofins (Luxemburgo) y Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnología
- Karius acaba de anunciar una recaudación de fondos de 100 millones de dólares. (publicado el 3 de mayo de 2024).
- Transcarent acaba de anunciar una recaudación de fondos de 126 millones de dólares. (publicado el 2 de mayo de 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (publicado el 2 de mayo de 2024).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Delix Therapeutics
- https://www.delixtherapeutics.com/news/delix-therapeutics-awarded-national-institutes-of-health-grant-to-advance-vital-research-of-novel-neuroplastogen-for-substance-use-disorders/
- https://www.delixtherapeutics.com/news/delix-presents-interim-data-from-phase-i-trial-of-novel-neuroplastogen-at-acnp-annual-meeting/
- https://www.delixtherapeutics.com/news/the-future-of-psychedelic-medicine-will-be-drugs-youve-never-heard-of/
- https://www.delixtherapeutics.com/news/delix-therapeutics-closes-30-million-convertible-note-financing-enters-10-million-strategic-credit-facility-option-in-partnership-with-comerica-bank/
- https://www.delixtherapeutics.com/news/drug-companies-are-investing-big-in-psychedelics-but-can-they-engineer-out-the-trip/
- Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability
- Pioneering Delix Therapeutics Study Published in 'Science' Elucidates the Mechanism of Psychedelic-Induced Neuroplasticity
- The Galien Foundation Announces 2023 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
- The Galien Foundation Announces 2023 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
- Delix Therapeutics Initiates Phase I Trial for Novel Compound DLX-001
- View more press releases Close
Redes sociales sobre Delix Therapeutics
- Delix Therapeutics en Wikipedia, Google News y Yahoo Finance
- Delix Therapeutics en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Nick Haft 
Llame a Delix Therapeutics al +1 832...
